These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8342580)

  • 21. Fludrocortisone therapy for persistent hyperkalaemia.
    Dobbin SJH; Petrie JR; Lean MEJ; McKay GA
    Diabet Med; 2017 Jul; 34(7):1005-1008. PubMed ID: 28375568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hyperkalemia in dialysis patients.
    Putcha N; Allon M
    Semin Dial; 2007; 20(5):431-9. PubMed ID: 17897250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE.
    Fishbane S; Ford M; Fukagawa M; McCafferty K; Rastogi A; Spinowitz B; Staroselskiy K; Vishnevskiy K; Lisovskaja V; Al-Shurbaji A; Guzman N; Bhandari S
    BMC Nephrol; 2022 Feb; 23(1):59. PubMed ID: 35135481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of use of dates on serum potassium in nondiabetic hemodialysis patients.
    Siddiqi N; El Shahat O; Bokhari E; Roujouleh H; Hamid MH; Sheikh I; El-Sayed H; Saleh A; Seddik A
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1018-22. PubMed ID: 19861864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of serum potassium during fasting in patients with end-stage renal disease.
    Gifford JD; Rutsky EA; Kirk KA; McDaniel HG
    Kidney Int; 1989 Jan; 35(1):90-4. PubMed ID: 2651754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K; Flynn J; Okamura D; Zhou L
    J Ren Nutr; 2013 Sep; 23(5):333-9. PubMed ID: 23707305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.
    Allon M; Shanklin N
    Am J Kidney Dis; 1996 Oct; 28(4):508-14. PubMed ID: 8840939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potassium balance in dialysis patients.
    Sanghavi S; Whiting S; Uribarri J
    Semin Dial; 2013; 26(5):597-603. PubMed ID: 24073843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus.
    Dreyling KW; Wanner C; Schollmeyer P
    Clin Nephrol; 1990 Apr; 33(4):179-83. PubMed ID: 2350905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
    Weir MR; Bakris GL; Bushinsky DA; Mayo MR; Garza D; Stasiv Y; Wittes J; Christ-Schmidt H; Berman L; Pitt B;
    N Engl J Med; 2015 Jan; 372(3):211-21. PubMed ID: 25415805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient.
    Ash SR; Singh B; Lavin PT; Stavros F; Rasmussen HS
    Kidney Int; 2015 Aug; 88(2):404-11. PubMed ID: 25651363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperkalaemia and haemodialysis patients: eletrocardiographic changes.
    Cobo Sánchez JL; Alconero Camarero AR; Casaus Pérez M; Maza Sota MA; Villa Llamazares C; Hiquera Roldán C; Menezo Viadero R; Alonso Nates R
    J Ren Care; 2007; 33(3):124-9. PubMed ID: 19160884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium zirconium cyclosilicate in hyperkalemia.
    Packham DK; Rasmussen HS; Lavin PT; El-Shahawy MA; Roger SD; Block G; Qunibi W; Pergola P; Singh B
    N Engl J Med; 2015 Jan; 372(3):222-31. PubMed ID: 25415807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperkalemia during prolonged use of angiotensin II-converting enzyme inhibitors in end-stage renal insufficiency].
    Mooser V; Fellay G; Regamey C
    Schweiz Med Wochenschr; 1992 Dec; 122(50):1927-9. PubMed ID: 1465596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the alpha-1-adrenergic receptor blocker doxazosin on exercise-induced hyperkalemia in hemodialysis patients.
    Nowicki M; Waluś T; Kokot F
    Kidney Blood Press Res; 2002; 25(1):55-60. PubMed ID: 11834878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism.
    Sebastian A; Schambelan M; Lindenfeld S; Morris RC
    N Engl J Med; 1977 Sep; 297(11):576-83. PubMed ID: 18672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study.
    Liou HH; Chiang SS; Wu SC; Huang TP; Campese VM; Smogorzewski M; Yang WC
    Am J Kidney Dis; 1994 Feb; 23(2):266-71. PubMed ID: 8311086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis.
    Bushinsky DA; Rossignol P; Spiegel DM; Benton WW; Yuan J; Block GA; Wilcox CS; Agarwal R
    Am J Nephrol; 2016; 44(5):404-410. PubMed ID: 27784004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fludrocortisone for the treatment of heparin-induced hyperkalemia.
    Sherman DS; Kass CL; Fish DN
    Ann Pharmacother; 2000 May; 34(5):606-10. PubMed ID: 10852087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.